Agricultural Biologicals Market Companies

Why Agricultural Biologicals Market Are Expanding?

The Agricultural Biologicals Market is experiencing sustained, accelerating expansion driven by a convergence of regulatory, technological, and macroeconomic forces. As per Market Research Future (MRFR) analysis, the market was valued at USD 11,505.69 million in 2024 and is projected to grow from USD 13,070.46 million in 2025 to USD 45,797.33 million by 2035, exhibiting a compound annual growth rate (CAGR) of 13.6% over the forecast period 2025–2035.

Biostimulants are the fastest growing sub-segment with a value of USD 3,178.08 million in 2024 and is projected to reach USD 15,879.72 million by 2035 as growers seek inputs that improve stress tolerance and nutrient efficiency without the danger of residue. The biopesticides category is the largest segment by revenue share, with an estimated 38% share of the total market revenue in 2024, driven by broad crop applicability, and rapid regulatory approvals for biopesticides in North America, Europe, and Asia-Pacific.

Why These Companies Are Leading the Market?

MRFR's competitive analysis identifies four structural factors that separate market leaders from the broader field in the Agricultural Biologicals Market, each exemplified by a specific company in the MRFR-profiled universe.

• Platform Breadth: Leaders with biopesticides, biofertilizers, biostimulants and microbial inoculants across numerous crops have pricing leverage and cross-selling advantages. An example is BASF SE, which has a BioSolutions range of bacterial fungicides, mycorrhizal inoculants and seaweed-derived biostimulants for more than 100 crops worldwide.
• Technology Differentiation: Proprietary biological platforms that are difficult to copy create sustainable competitive advantages. Syngenta AG has been working to achieve this through its collaboration with Biotalys and the AGROBODY™ protein-based biocontrol technology to deliver novel modes of action against resistant pest populations, directly responding to the market’s resistance management imperative.
• Geographic Coverage and Local Formulation: Companies utilizing a worldwide registration infrastructure with local customized product formulations will have access to the fastest expanding emerging markets. Koppert B.V. provides the largest dedicated biological distribution network on the market, serving more than 100 countries with regionally adapted biocontrol programmes for integrated pest management.
• M&A-Led Scale and Speed: Strategic acquisitions are the fastest route to building portfolio depth and channel access in biologicals. UPL's 2023 acquisition of Valent BioSciences expanded its bionematicide and biofungicide capabilities in North America, establishing a full-spectrum biological offering that competes directly with larger agrochemical conglomerates.

Top 10 Global Agricultural Biologicals Companies (2026-2035)

1. BASF SE  |  ETR: BAS  |  Ludwigshafen, Germany

BASF SE is the world’s largest chemical company by revenue and has one of the broadest agricultural biologicals portfolios in the industry through its Agricultural Solutions division, which includes the BioSolutions product line, including biofungicides (Serenade Biocontrol), mycorrhizal inoculants, plant extracts and seaweed-derived biostimulants. BASF supports growers in over 90 countries and is focused on cereals, fruits, vegetables and specialty crops with integrated biological programs. Leveraging its strategic position in agricultural biologicals, it utilizes legacy chemistry distribution infrastructure and dedicated biological formulation and fermentation capabilities to provide unequaled channel reach in this industry.

Acadian Plant Health’s biostimulants based on Ascophyllum nodosum, which contain polysaccharides, mannitol and betaines, are to be included in BASF’s BioSolutions portfolio and are to be rolled out globally beyond the existing European and Chinese markets, following a distribution agreement signed in October 2025.

2. Bayer AG (Bayer CropScience)  |  ETR: BAYN  |  Leverkusen, Germany

Bayer AG, through its Crop Science division, operates one of the largest integrated crop protection businesses globally, with a growing biological segment that includes the Serenade range of biofungicides (Bacillus subtilis QST 713), the bayer sold the entire CONTANS business to Lallemand Plant Care effective. Bayer serves growers in more than 140 countries and has embedded biologicals as an integral component of its integrated pest management and digital farming ecosystem, including its Climate FieldView precision agriculture platform.

In January 2024, Bayer received U.S. regulatory approval for Serenade ASO, expanding its biofungicide commercial footprint in North America's high-value fruit and vegetable segments.

3. Syngenta AG (Syngenta Biologicals)  |  Private (ChemChina ownership)  |  Basel, Switzerland

Syngenta AG has assembled a systematic biologicals portfolio via its dedicated Syngenta Biologicals unit, which encompasses microbial bioinsecticides, biofungicides, biostimulants and pheromone-based semiochemicals. The company is present in more than 100 countries and has crop specific biological programs for cereals, vegetables and high value specialty crops. Syngenta’s biologicals strategy is underpinned by a dedicated discovery pipeline that complements its core synthetic chemistry business with a stated goal of bringing multiple differentiated biological registrations to market yearly through 2030.

In April 2025, Syngenta Crop Protection and Biotalys have announced a collaboration to research, develop and commercialise new biocontrol solutions based on Biotalys’ AGROBODY™ technology platform to key insect pests across a broad range of crops and a novel mode of action to counter pesticide resistance.

4. Corteva Agriscience  |  NYSE: CTVA  |  Wilmington, Delaware, USA

Specialized biologicals strategy through its crop protection and seed platforms. Active in over 140 countries with biostimulants, biological seed treatments and biopesticides for cereals, oilseeds and specialty crops. Spun off on June 1, 2019 from Corteva Agriscience. The company expedited its biologicals build-out with the 2022 acquisition of The Stoller Group, adding a range of plant nutrition biologicals and biostimulants with particularly strong North American and Latin American distribution. Corteva’s biologicals portfolio is positioned as part of their complete farm systems strategy and includes biological inputs with the Enlist herbicide-tolerant and Brevant seed brands.

Corteva’s FY2024 total net sales of USD 16.9 billion. The Crop Protection business saw modest growth with biologicals and sustainability-linked products offsetting synthetic volume challenges. The company’s FY2023 crop protection portfolio’s biologicals income rose 20% due to biostimulant uptake across North American corn and soybean acres, according its 2024 Sustainability Report.

5. UPL Ltd.  |  NSE: UPL  |  Mumbai, India

UPL Ltd. is among the most aggressive builders of a global biological platform of the top-tier agrochemical companies, operating in over 130 countries with a biologicals portfolio of biofungicides, bionematicides, bioherbicides and biostimulants sold through its Natural Plant Protection (NPP) and Arysta LifeScience units. UPL’s biologicals approach is anchored by the merger of Arysta LifeScience (acquired FY2019) and more recently, Valent BioSciences (acquired September 2023), offering it complete biological product registration data across North America, Europe and APAC.

UPL showcased its enhanced biopesticide range for insect pest control and disease management in row crops and specialty segments at the World Biocontrol Congress in December 2023. In September 2023, UPL considerably expanded its biologicals portfolio in its most challenging regulatory market with the acquisition of Valent BioSciences, a leader in biofungicides and bionematicides with retail presence in North America.

6. Valent BioSciences (UPL subsidiary)  |  Private  |  Libertyville, Illinois, USA

Valent BioSciences, now operating as subsidiary of Tokyo-based Sumitomo Chemical Co., Ltd, is a leading developer and manufacturer of biopesticide products including DiPel (Bt-based bioinsecticide), XenTari (Bt aizawai bioinsecticide), and a range of biofungicides and bionematicides for specialty and row crops. The company's products are registered and sold in more than 60 countries, with particular strength in North American row crops, California specialty vegetables, and European integrated pest management programmes. Its manufacturing facilities in Osage, Iowa provide the fermentation capacity backbone for UPL's global biopesticide supply chain.

Following the completion of the UPL acquisition in September 2023, Valent BioSciences has been actively integrating into the broader UPL Biologicals platform, with combined sales force deployment and joint product positioning across North America initiated in 2024.

7. Koppert B.V.  |  Private  |  Berkel en Rodenrijs, Netherlands

Koppert B.V. is the world’s leading dedicated biological control and natural pollination company, providing growers with an exclusive network of biological solutions including beneficial insects (predatory mites, parasitic wasps), entomopathogenic fungi and microbial biocontrol agents for integrated pest management in more than 100 countries. Founded in 1967, Koppert’s main competitive advantage is its product-to-grower advice service model that combines biological product supply with in-field agronomist support and thereby considerably reduces biological efficacy risk for commercial producers switching from synthetic programmes.

Koppert launched its digital consultancy platform BioPortect in Asia Pacific markets in 2025, combining crop monitoring data with biological programme recommendations to cater to the region's fastest rising adoption curve for biologicals.

8. Arysta LifeScience (UPL subsidiary)  |  Private (UPL subsidiary)  |  Tokyo, Japan

Arysta LifeScience is a specialist agricultural inputs firm with a large biologicals portfolio, focusing on biostimulants, specialty biopesticides and plant health products in more than 80 countries, after its acquisition by UPL Ltd in 2019. UPL’s APAC-heavy footprint, especially Japan, South Korea and Southeast Asia, gives the company unique access to regulated, high-residue-sensitivity markets where biological alternatives trade at considerable price premiums. Arysta's crop nutrition and biosolutions product portfolio includes biostimulants, soil health products and biofungicides for rice, vegetable and fruit crops.

In 2024-2025, Arysta’s APAC biologicals portfolio was integrated into the larger UPL biologicals platform, allowing the combined marketing of Arysta’s specialty APAC biostimulants with Valent BioSciences’ biopesticides in markets such as Japan, Thailand and Vietnam, where organic conversion rates are on the rise.

9. Novonesis (formerly Novozymes)  |  CPH: NSIS-B  |  Bagsvaerd, Denmark

Novonesis — formed through the January 2024 merger of Novozymes and Chr. Hansen — is the world's leading provider of biological solutions spanning agricultural microbials, food fermentation cultures, and enzyme solutions, with its Agriculture biological products serving growers in more than 45 countries. Its agricultural biologicals portfolio includes microbial inoculants (Rhizobium, Bradyrhizobium, and Azospirillum strains for legumes and cereals), biofertilizers, and mycorrhizal products deployed primarily in North America, Brazil, and Europe. Novonesis brings unmatched fermentation science and microbial strain development capability to the agricultural biologicals competitive set.

The merger between Novozymes and Chr. Hansen, completed in January 2024 to form Novonesis, established a combined entity with DKK 28.7 billion in total revenue (FY2024) and a dedicated agriculture biologicals R&D unit with significantly expanded genomic screening capability for novel microbial strain discovery.

10. Marrone Bio Innovations (Bioceres Crop Solutions subsidiary)  |  Private  |  Davis, California, USA

Marrone Bio Innovations (MBI), now operating as a subsidiary of Bioceres Crop Solutions, is a leading U.S.-based developer of biological crop protection and plant health products, with a portfolio including Regalia (Reynoutria sachalinensis plant extract biofungicide), Grandevo (Chromobacterium subtsugae bioinsecticide), Venerate (Burkholderia spp. bioinsecticide), and Stargus biofungicide. MBI's products address disease, insect pest, and plant health challenges across more than 30 countries, with particular strength in California specialty crops and Latin American export agriculture.

In 2025, MBI's Regalia Rx biofungicide was expanded into multiple Latin American markets through the Bioceres distribution network, targeting high-value soybean and corn disease management programmes in Brazil and Argentina where synthetic fungicide resistance pressure is accelerating biological adoption.

R&D Investment & Innovation Signals

R&D investment across the Agricultural Biologicals Market has accelerated materially in 2025–2026, as companies prioritise next-generation microbial strain development, formulation stability enhancement, and AI-integrated precision application systems to close the efficacy and shelf-life gap with synthetic alternatives — the primary adoption barrier among commercial growers identified by MRFR primary research.

• BASF SE has increased its Crop Protection R&D programme in Limburgerhof, Germany, with dedicated biologicals fermentation and formulation screening capacity in 2025 to focus on stable liquid Bacillus strains with 24-month ambient shelf life for global tropical markets.
• Bayer AG announced a USD 100 million investment in a new biologicals R&D centre in Brazil in November 2023, with activities expected to begin in 2025 to focus on biofungicide strain identification to address disease management concerns for soybean and sugarcane in tropical soil microbiomes.
• Syngenta AG has agreed to a multi-year funded research program with Biotalys, which commenced in April 2025. The program is designed to create protein-based AGROBODY biocontrol molecules for specific insect pest targets in cereal, vegetable, and specialty crops. The commercial product targets are set for the 2028–2030 registration window.
• Corteva Agriscience has strengthened its biologicals discovery pipeline with the acquisition of Stoller Group, applying plant physiology-based biostimulant R&D methods through its Corteva Catalyst open innovation platform to identify early-stage biological start-ups worldwide.
• UPL Ltd. has established a Global Biologicals Centre of Excellence in São Paulo, Brazil (2024), bringing together Valent BioSciences and legacy UPL biological R&D teams to speed fermentation process development for bionematicides and biofungicides for Latin American row-crop markets.
• Koppert B.V. has invested in next-generation beneficial insect rearing automation and AI-powered crop monitoring integration through its BioPortect platform, enabling precision timing of biocontrol release events to maximise efficacy across variable climate conditions.
• Novonesis has deployed combined genomic screening infrastructure from the merged Novozymes–Chr. Hansen platform to accelerate discovery of novel nitrogen-fixing microbial strains for non-legume crops — specifically targeting the corn and wheat microbiome — with human-guided AI tools reducing strain screening cycles by approximately 40%.
• Marrone Bio Innovations (Bioceres) has accelerated development of combination biological products that stack its Regalia plant-extract biofungicide with Bioceres HB4 drought-tolerance trait technology, creating integrated biological-biotech solutions that address both abiotic and biotic stress in Latin American row crops.